FrancophonIA/ELRC3.0 huggingface dataset:
English: The effects of Eklira Genuair last for 12 hours; therefore, you should try to use your Eklira Genuair inhaler at the same time every morning and evening.
Danish: Du skal derfor forsøge at bruge Eklira Genuairinhalatoren på samme tid hver morgen og aften.
English: Eklira Genuair did not increase the MACE risk in patients with COPD compared to placebo when added to current background therapy (hazard ratio (HR) 0.89; 95% CI: 0.64, 1.23).
Danish: Eklira Genuair øgede ikke MACE-risikoen for patienter med KOL sammenlignet med placebo ved tilføjelse til den igangværende baggrundsbehandling (hazard ratio (HR) 0,89; 95 % CI: 0,64, 1,23).
English: EU/1/12/778/003 3 inhalers each containing 60 doses
Danish: EU/1/12/778/003 3 inhalatorer hver med 60 doser
English: The most frequently reported adverse reactions with Eklira Genuair were headache (6.6%) and nasopharyngitis (5.5%).
Danish: Sammendrag af sikkerhedsprofilen Den hyppigst rapporterede bivirkning med Eklira Genuair var hovedpine (6,6 %) og nasopharyngitis
English: If you are not sure of how to use Eklira Genuair, contact your doctor or pharmacist.
Danish: Er du i tvivl om, hvordan du skal bruge Eklira Genuair, så spørg lægen eller apotekspersonalet.
English: The frequencies assigned to the undesirable effects listed below are based on crude incidence rates of adverse reactions (i.e. events attributed to Eklira Genuair) observed with Eklira Genuair 322 µg (636 patients) in the pooled analysis of one 6-month and two 3-month randomised, placebo-controlled clinical trials.
Danish: Hyppighederne tildelt bivirkningerne angivet i listen nedenfor er baseret på summariske incidensrater for bivirkninger (dvs. hændelser tilskrevet Eklira Genuair) iagttaget med Eklira Genuair 322 µg (636 patienter) i den poolede analyse af et 6-måneders og to 3-måneders randomiserede, placebokontrollerede kliniske studier.
English: What you need to know before you use Eklira Genuair
Danish: Det skal du vide, før du begynder at bruge Eklira Genuair
English: In a 3-week crossover, randomised, placebo-controlled clinical study Eklira Genuair was associated with a statistically significant improvement in exercise endurance time in comparison to placebo of 58 seconds (95% CI=9-108; p=0.021; pre-treatment value: 486 seconds).
Danish: I et 3-ugers randomiseret, placebokontrolleret klinisk overkrydsningsstudie blev Eklira Genuair forbundet med en statistisk signifikant forbedring af udholdenhedstiden ved motion på 58 sekunder sammenlignet med placebo (95 % CI=9-108; p=0,021; værdi før behandling: 486 sekunder).
English: In addition, Eklira Genuair showed a statistically significant reduction of 35% in the rate of hospitalisations due to COPD exacerbations while on-treatment during the first year compared with placebo (RR 0.65; 95% CI 0.48 to 0.89; p=0.006).
Danish: Desuden viste Eklira Genuair en statistisk signifikant reduktion på 35 % i antallet af hospitalsindlæggelser på grund af KOL-eksacerbationer under behandlingen i det første år sammenlignet med placebo (RR 0,65; 95 % CI 0,48 til 0,89; p=0,006).
English: Other medicines and Eklira Genuair
Danish: Brug af anden medicin sammen med Eklira Genuair
English: Patients treated with Eklira Genuair showed a statistically significant reduction of 22% compared to placebo (rate ratio [RR] 0.78; 95% CI 0.68 to 0.89; p<0.001).
Danish: Patienter behandlet med Eklira Genuair udviste en statistisk signifikant reduktion på 22 % i sammenligning med placebo (frekvensratio [RR] 0,78; 95 % CI 0,68 til 0,89; p<0,001).
English: Clinical efficacy studies showed that Eklira Genuair provided clinically meaningful improvements in lung function (as measured by the forced expiratory volume in 1 second [FEV1]) over 12 hours following morning and evening administration, which were evident within 30 minutes of the first dose (increases from baseline of 124-133 mL).
Danish: Kliniske studier viser, at Eklira Genuair medfører klinisk meningsfulde forbedringer i lungefunktion (målt ved forceret ekspiratorisk volumen på 1 sekund [FEV1]) over 12 timer efter administration morgen og aften.
English: Eklira Genuair 322 micrograms inhalation powder
Danish: Eklira Genuair 322 mikrogram inhalationspulver
English: A placebo-controlled trial in 1791 patients with moderate to very severe COPD treated with Eklira Genuair up to 36 months did not identify other adverse reactions.
Danish: Der blev ikke identificeret andre bivirkninger i et placebokontrolleret studie med 1.791 patienter med moderat til meget svær KOL, som blev behandlet med Eklira Genuair i op til 36 måneder.
English: Pack sizes supplied:
Danish: Eklira Genuair indeholder:
English: EU/1/12/778/001 30 doses
Danish: EU/1/12/778/001 30 enhedsdoser
English: EU/1/12/778/002 60 doses
Danish: EU/1/12/778/002 60 enhedsdoser
English: In vitro studies have shown that aclidinium bromide or the metabolites of aclidinium bromide at the therapeutic dose are not expected to cause interactions with active substances that are substrates of P-glycoprotein (P-gp), or active substances metabolised by cytochrome P450 (CYP450) enzymes and esterases (see section 5.2).
Danish: glykoprotein (P-gp) eller aktive stoffer, der metaboliseres af cytochrom P450 (CYP450)-enzymer og-esteraser (se pkt.
English: If you stop using Eklira Genuair
Danish: Hvis du har brugt for meget Eklira Genuair
English: Eklira Genuair 322 micrograms inhalation powder aclidinium (aclidinium bromide)
Danish: Eklira Genuair 322 mikrogram inhalationspulver aclidinium (aclidiniumbromid)
English: How to use Eklira Genuair
Danish: Sådan skal du bruge Eklira Genuair
English: If you use more Eklira Genuair than you should If you think you may have used more Eklira Genuair than you should, contact your doctor or pharmacist.
Danish: Spørg lægen eller apotekspersonalet, hvis du mener, at du har brugt mere Eklira Genuair, end du burde.
English: What Eklira Genuair contains - The active substance is aclidinium bromide.
Danish: - Aktivt stof: aclidiniumbromid.
English: What Eklira Genuair is and what it is used for What you need to know before you use Eklira Genuair How to use Eklira Genuair
Danish: Det skal du vide, før du begynder at bruge Eklira Genuair Sådan skal du bruge Eklira Genuair Bivirkninger
English: Eklira Genuair 322 mcg inhalation powder aclidinium (aclidinium bromide) Inhalation use
Danish: Eklira Genuair 322 µg inhalationspulver aclidinium (aclidiniumbromid) Inhalationsbrug
English: How to store Eklira Genuair Contents of the pack and other information Instructions for Use
Danish: Pakningsstørrelser og yderligere oplysninger Brugsanvisning
English: - This medicine has been prescribed for you only.
Danish: - Lægen har ordineret dette lægemiddel til dig personligt Lad derfor være med at give medicinen til andre.
English: * Relative potency (ELISA test) by comparison with a reference vaccine
Danish: *Relativ Potency (ELISA test) ved sammenligning med referencevaccine
English: Adjuvant: Carbomer
Danish: Adjuvans: Carbomer
English: Vaccinate healthy animals only.
Danish: Vaccinér kun raske dyr.
English: Adjuvant: Carbomer 1 mg.
Danish: Adjuvans: Carbomer 1 mg
English: Date of first authorisation: 24.05.2017
Danish: DATO FOR FØRSTE TILLADELSE/FORNYELSE AF TILLADELSEN Dato for første markedsføringstilladelse: 24.05.2017
English: Overdose (symptoms, emergency procedures, antidotes) Following the administration of a 4-fold overdose of vaccine no adverse reactions other than those described under section “Adverse reactions” have been observed.
Danish: Overdosis (symptomer, nødforanstaltninger, modgift) Efter administration af fire gange så store doser som anbefalet er der ikke rapporteret bivirkninger ud over dem, der er nævnt under ”Bivirkninger”.
English: Interactions with other medicinal products and other forms of interaction Safety and efficacy data are available which demonstrate that this vaccine can be mixed with Ingelvac MycoFLEX and administered at one injection site.
Danish: Interaktion med andre lægemidler og andre former for interaktion Tilgængelige data for sikkerhed og virkning viser, at vaccinen kan blandes med Ingelvac MycoFLEX og administreres på ét injektionssted.
English: Ingelvac PCV FLEX suspension for injection for pigs
Danish: Ingelvac PCV FLEX injektionsvæske, suspension til grise
English: Each vial is closed with a chlorobutyl stopper and lacquered aluminium seal.
Danish: Hver flaske er lukket med chlorobutyl-gummiprop og forseglet med aluminiumhætte.
English: Do not mix with any other veterinary medicinal product, except with Ingelvac MycoFLEX (not for use in pregnant or lactating pigs).
Danish: Må ikke blandes med andre lægemidler til dyr, undtagen med Ingelvac MycoFLEX (må ikke anvendes til drægtige eller diegivende grise).
English: D. CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION
Danish: D. ANDRE FORHOLD OG BETINGELSER FOR MARKEDSFØRINGS-TILLADELSEN
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reactions) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Danish: - Almindelige (flere end 1, men færre end 10 dyr ud af 100 behandlede dyr) - Ualmindelige (flere end 1, men færre end 10 dyr ud af behandlede 1.000 dyr) - Sjældne (flere end 1, men færre end 10 dyr ud af behandlede 10.000 dyr) - Meget sjælden (færre end 1 dyr ud af 10.000 behandlede dyr, herunder isolerede rapporter)
English: Safety and efficacy data are available which demonstrate that this vaccine can be mixed with Ingelvac MycoFLEX and administered at one injection site.
Danish: Tilgængelige data for sikkerhed og virkning viser, at vaccinen kan blandes med Ingelvac MycoFLEX og administreres på ét injektionssted.
English: b) the disease to which the product is intended to confer immunity is largely absent from the territory in question.
Danish: b) at den sygdom, som veterinærlægemidlet er beregnet til at fremkalde immunitet mod, stort set
English: Name and address of the manufacturer of the biological active substance Boehringer Ingelheim Vetmedica Inc.
Danish: Navn og adresse på fremstilleren (fremstillerne) af de(t) biologisk aktive stof Boehringer Ingelheim Vetmedica Inc.
English: The PSURs for Ingelvac PCV FLEX shall be submitted at the same frequency as for Ingelvac CircoFLEX.
Danish: PSUR'er for Ingelvac PCV FLEX skal indsendes med samme hyppighed som for Ingelvac CircoFLEX.
English: • Use the same volumes of Ingelvac PCV FLEX and Ingelvac MycoFLEX.
Danish: • Brug samme mængde af Ingelvac PCV FLEX og Ingelvac MycoFLEX.
English: For active immunisation of pigs with no PCV2 maternally derived antibodies from the age of 2 weeks against porcine circovirus type 2 (PCV2).
Danish: For aktiv immunisering af grise uden PCV2 overført fra moderen fra 2 ugers alderen mod porcint circovirus type 2 (PCV2).
English: If needed, gently press the vaccine bottle of Ingelvac PCV FLEX to facilitate the transfer.
Danish: Hvis nødvendigt, tryk forsigtigt på vaccineflasken med Ingelvac PCV FLEX for at lette overførslen.
English: Active substance: Porcine circovirus type 2 ORF2 protein
Danish: Aktivt stof: Porcint circovirus type 2 ORF2-protein
English: Porcine circovirus type 2 ORF2 protein: RP* 1.0-3.75 * Relative potency (ELISA test) by comparison with a reference vaccine.
Danish: Porcint circovirus type 2 ORF2-protein * Relativ Potency (ELISA test) ved sammenligning med referencevaccine.
English: When mixed with Ingelvac MycoFLEX the following recommendations should be followed:
Danish: Når lægemidlet blandes med Ingelvac MycoFLEX bør følgende anbefalinger følges:
English: Under experimental challenge conditions in which only seronegative animals were included, it was demonstrated that vaccination reduces mortality, clinical signs and lesions in lymphoid tissues associated with PCV2 related disease (PCVD).
Danish: Under forsøgsforhold, hvor kun seronegative dyr var inkluderet, blev det påvist, at vaccination reducerer dødelighed, kliniske symptomer og læsioner i lymfevæv som følge af PCV2 relaterede sygdomme (PCVD).
English: One dose (1 ml) contains: Porcine circovirus type 2 ORF2 protein Carbomer 1 mg.
Danish: En dosis (1 ml) indeholder: Porcint circovirus type 2 ORF2-protein Carbomer 1 mg
English: Pharmacotherapeutic group: Immunologicals for suidae, inactivated viral vaccines for pigs ATCvet code: QI09AA07
Danish: Farmakoterapeutisk gruppe: Immunologiske midler til svin (suidae), inaktiverede virale vacciner til svin
English: One dose (1 ml): Porcine circovirus type 2 ORF2 protein Carbomer
Danish: En dosis (1 ml): Porcint circovirus type 2 ORF2-protein Carbomer
English: - After the transfer of the full content of Ingelvac PCV FLEX, disconnect and discard transfer needle and empty vaccine bottle of Ingelvac PCV FLEX.
Danish: - Når alt indholdet af Ingelvac PCV FLEX er overført, fjernes og kasseres kanylen og den tomme vaccineflaske med Ingelvac PCV FLEX.
English: A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
Danish: A. FREMSTILLER AF DE(T) BIOLOGISK AKTIVE STOF OG FREMSTILLER
English: - Transfer the Ingelvac PCV FLEX vaccine into the vaccine bottle of Ingelvac MycoFLEX.
Danish: - Overfør Ingelvac PCV FLEX vaccinen til vaccineflasken med Ingelvac MycoFLEX.
English: Name and address of the manufacturers responsible for batch release Boehringer Ingelheim Vetmedica GmbH 55216 Ingelheim/Rhein
Danish: Navn og adresse på fremstilleren (fremstillerne) ansvarlig for batchfrigivelse Boehringer Ingelheim Vetmedica GmbH 55216 Ingelheim/Rhein
English: 10 ml, 50 ml bottle
Danish: 10 ml, 50 ml flasker
English: Pack sizes of 1 or 12 bottles of 10 ml (10 doses), 50 ml (50 doses), 100 ml (100 doses) or 250 ml (250 doses).
Danish: Pakningsstørrelser med på 1 eller 12 flasker à 10 ml (10 doser), 50 ml (50 doser), 100 ml (100 doser) eller 250 ml (250 doser).
English: 100 ml, 250 ml bottle
Danish: 100 ml, 250 ml flasker
English: Carton of 10 ml, 50 ml, 100 ml, 250 ml bottles
Danish: Æske med 10 ml, 50 ml, 100 ml, 250 ml flasker
English: Pack sizes of 1 or 12 high density polyethylene bottles of 10 ml (10 doses), 50 ml (50 doses), 100 ml (100 doses) or 250 ml (250 doses).
Danish: Pakningsstørrelser med 1 eller 12 højdensitet polyethylen hætteglas à 10 ml (10 doser), 50 ml (50 doser), 100 ml (100 doser) eller 250 ml (250 doser).
English: - Connect the opposite end of the transfer needle to the vaccine bottle of Ingelvac PCV FLEX.
Danish: - Tilslut den modsatte ende af overførselskanylen til vaccineflasken med Ingelvac PCV FLEX.
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reactions) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated)
Danish: Hyppigheden af bivirkninger er defineret som: - Meget almindelig (flere end 1 ud af 10 behandlede dyr, der viser bivirkninger i løbet af en behandling)
English: Marketing authorisation holder and manufacturer responsible for batch release: Boehringer Ingelheim Vetmedica GmbH 55216 Ingelheim/Rhein
Danish: Indehaver af markedsføringstilladelsen og fremstiller ansvarlig for af batchfrigivelse: Boehringer Ingelheim Vetmedica GmbH
English: EU/2/19/247/001 Mirataz
Danish: EU/2/19/247/001 Mirataz 20 mg/ g
English: 1 tube Not applicable
Danish: 1 tube Ikke relevant
English: Cats Transdermal use Tube (Alu) 5 g
Danish: Tube (alu) 5 g
English: EU (MA) Number
Danish: Bilag A
English: Strength Pharmaceutical form
Danish: Særnavn Styrke Lægemiddelform Dyrearter, som lægemidle t er beregnet til
English: Target species
Danish: Transdermal anvendelse
English: Content Package size
Danish: Indhold Pakning sstørrel se
English: If you or your daughter:
Danish: Hvis du eller din datter:
English: This product contains genetically modified organisms (GMOs).
Danish: Produktet indeholder genetisk modificerede organismer (GMO'er).
English: Your doctor will carefully consider the risks and benefits of vaccination.
Danish: Din læge vil nøje overveje risiciene og fordelene ved vaccination.
English: N: number of subjects per study
Danish: N: antal personer per studie
English: Symptoms usually last for 2 to 7 days.
Danish: Symptomer varer som regel i 2 til 7 dage.
English: • The first injection will be given at the chosen or scheduled date.
Danish: • Den første injektion gives på den valgte eller planlagte dato.
English: It contains versions of these 4 varieties of the virus that have been weakened so that they cannot cause the disease.
Danish: Den indeholder versioner af disse 4 varianter af virussen, som er blevet svækkede, så de ikke kan forårsage sygdommen.
English: The following side effects occurred during studies in children, young people and adults.
Danish: Følgende bivirkninger forekom under studier hos børn, unge og voksne.
English: No cases of overdose have been reported.
Danish: Ingen tilfælde af overdosering er blevet indberettet.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION
Danish: 2 KVALITATIV OG KVANTITATIV SAMMENSÆTNING
English: Other serious reactions
Danish: Andre alvorlige reaktioner
English: • There is any suspicion that the partially used vial has been contaminated.
Danish: • Der er mistanke om, at det delvist brugte hætteglas er blevet kontamineret.
English: The bridging of efficacy is based on above available data and overall results.
Danish: Bridging af effekt er baseret på ovenstående tilgængelige data og samlede resultater.
English: You or your child will receive 3 injections of 0.5 mL - one every 6 months.
Danish: Du eller dit barn vil få 3 injektioner af 0,5 ml - én hver 6. måned.
English: Endemic areas are areas where the disease has been continuously present among the people who live there and where outbreaks or epidemics have occurred.
Danish: Endemiske områder er områder, hvor sygdommen vedvarende har været til stede blandt personer, som bor der, og hvor der har været udbrud eller epidemier.
English: • a mild to high fever or acute disease.
Danish: • har mild til høj feber eller akut sygdom.
English: A partially used multidose vial must be discarded immediately if:
Danish: Et delvist brugt flerdosis hætteglas skal øjeblikkeligt kasseres, hvis:
English: Additional side effects in adults:
Danish: Yderligere bivirkninger hos voksne:
English: No specific studies have been performed on fertility.
Danish: Ingen specifikke studier er blevet udført vedrørende fertilitet.
English: • There is visible evidence of contamination, such as a change in appearance.
Danish: • Der er synligt tegn på kontaminering, som f.eks. en ændring i udseende.
English: These data are inconclusive due to the low number of cases in the immunogenicity subset.
Danish: Disse data er inkonklusive på grund af det lave antal tilfælde i immunogenicitetsundergruppen.
English: This may be due to a genetic defect or HIV infection.
Danish: Dette kan skyldes en genetisk defekt eller HIV-infektion.
English: Children and adults 9 to 45 years of age
Danish: Børn og voksne i alderen fra 9 til 45 år
English: Therefore, protection is expected in adults in endemics areas although the actual magnitude of efficacy relative to that observed in children and adolescents is unknown.
Danish: Beskyttelse forventes derfor hos voksne i endemiske områder, omend det faktiske omfang af effekt, sammenlignet med beskyttelse observeret hos børn og unge, ikke er kendt.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 12 December 2018
Danish: Dato for første markedsføringstilladelse: 12 december 2018
English: Younger children Children less than 9 years of age must not receive the vaccine.
Danish: Børn på under 9 år må ikke få vaccinen.
English: Study N
Danish: Studie N
English: The adverse reactions were usually mild to moderate in severity and of short duration (0 to 3 days).
Danish: Bivirkningerne var som regel af let til moderat sværhedsgrad og af kort varighed (0 til 3 dage).
English: Occasionally dengue can be severe enough for you to have to go to hospital and in rare cases it can cause death.
Danish: Undertiden kan denguefeber være alvorlig nok til, at du er nødt til at tage på hospitalet, og i visse tilfælde kan sygdommen forårsage dødsfald.
English: You can also have dengue but show no symptoms (called "asymptomatic").
Danish: Du kan også have denguefeber uden symptomer (dette kaldes "asymptomatisk").
English: Read the package leaflet before use and for reconstitution instructions.
Danish: Læs indlægssedlen inden brug og for instruktioner til rekonstitution.
English: This is because Dengvaxia might not work as well.
Danish: Det skyldes, at Dengvaxia muligvis ikke vil virke lige så godt.
English: CYD22: Vietnam; CYD28: Singapore; CYD47: India;
Danish: CYD22: Vietnam; CYD28: Singapore; CYD47: Indien;
English: In the following Tables the dengue serostatus at baseline (before the first injection), was defined as:
Danish: I følgende tabeller var dengue-serostatus ved baseline (inden den første injektion) defineret som:
English: CYD28: Low endemic country
Danish: CYD28: Lav-endemisk land
English: These signs or symptoms (anaphylactic reactions) usually develop soon after the injection is given and while you or your child are still in the clinic or doctor's surgery.
Danish: Disse tegn eller symptomer (anafylaktiske reaktioner) forekommer som regel umiddelbart efter, at injektionen er givet, og mens du/dit barn stadig er på klinikken eller i lægens praksis.
English: • Individuals with symptomatic HIV infection or with asymptomatic HIV infection when accompanied by evidence of impaired immune function.
Danish: • Personer med symptomatisk HIV-infektion eller med asymptomatisk HIV-infektion, når det er ledsaget af tegn på svækket immunfunktion.
English: If any of these symptoms occur after leaving the place where you or your child received an injection, contact a doctor immediately:
Danish: Hvis nogen af disse symptomer forekommer, efter du forlader stedet, hvor du eller dit barn fik injektionen, skal du straks søge læge:
English: The powder and the solvent must be mixed together before use.
Danish: Pulver og solvens skal blandes inden brug.
English: This leaflet was last revised in [{MM/YYYY}].
Danish: Denne indlægsseddel blev senest ændret [{mm/ÅÅÅÅ}].
English: Instructions for preparing the vaccine intended for medical and healthcare professionals are included at the end of the leaflet.
Danish: Instruktioner i klargøring af vaccinen beregnet til læger og sundhedspersonale er inkluderet sidst i indlægssedlen.
English: Most of the subjects were 9 to 17 years of age (n= 2810).
Danish: De fleste af personerne var i alderen fra 9 til 17 år (n=2.810).
English: Administration of Dengvaxia must be postponed in individuals suffering from moderate to severe febrile or acute disease.
Danish: Administration af Dengvaxia skal udskydes hos personer, der lider af moderat til svær feber eller akut sygdom.
English: A decrease in the GMTs against all 4 serotypes was observed one year after the third injection.
Danish: En reduktion i GMT'er for alle 4 serotyper blev observeret et år efter den tredje injektion.
English: There was no shedding of Dengvaxia RNA in a distribution and shedding study, hence no risk of dissemination to the environment or transmission from vaccinees.
Danish: Der sås ingen ekskretion af Dengvaxia RNA i et fordelings- og ekskretionsstudie, så der er ingen risiko for spredning til miljøet eller overførsel fra vacciner.
English: The Control Group in dengue studies was defined as subjects who received at least one injection of placebo or comparator vaccine.
Danish: Kontrolgruppen i denguestudierne var defineret som personer, der modtog mindst én injektion med placebo eller komparator-vaccine.
English: This includes using insect repellents, wearing protective clothing, and using mosquito nets.
Danish: Det omfatter brug af insektbekæmpende midler, beskyttende tøj og myggenet.
English: Dengvaxia is a vaccine.
Danish: Dengvaxia er en vaccine.